M. Pharm Project Topic

M.Pharm Project (Thesis)

S.No	Projects
DST M.Pharm 01	Formulation and evaluation of topical formulations of bosweellic acids guggulosterones for the treatment of rheumatoid arthritis
DST M.Pharm 02	Spramolecular: nanomedicine and nanotechnology pre-concentration, separation and recovery of toxic trace metal
DST M.Pharm 03	Supercritical fluid technology
DST M.Pharm 04	Studies on design and development of dissolvable oral drug delivery systems of a poorly water soluble non-steroidal anti-inflammatory drug
DST M.Pharm 05	Designing of a polyherbal formulation for metabolic disorder
DST M.Pharm 06	Development of lipidic drug delivery system for bioavailability improvement of the poorly water soluble antihypertensive drug
DST M.Pharm 07	Formulation, development of rapidly dissolving films containing anti-histaminic drug
DST M.Pharm 08	Formulation and evaluation of colon targeted drug delivery systems
DST M.Pharm 09	Formulation, development and evaluation of controlled drug delivery of analgesics via novel routes
DST M.Pharm 010	Drug-induced diseases and teratogenicity
DST M.Pharm 011	Drug dependences, drug abuse, addictive drugs and their treatment, complications.
DST M.Pharm 012	Introduction to drying processes – study of tray dryers: fluidized bed dryer.
DST M.Pharm 013	Vacuum dryer and freeze dryer.
DST M.Pharm 014	Viscosity-imparting agents in disperse systems
DST M.Pharm 015	Oral aqueous suspensions
DST M.Pharm 016	Topical suspensions a review
DST M.Pharm 017	Bio-availability of drugs, including factors affecting it
DST M.Pharm 018	Complete data base of drug available by any source like internet, libraries etc.
DST M.Pharm 019	Complete physico0chemical parameter of pure drug.
DST M.Pharm 020	Study of complete drug profile from authenticated sources like pharmacopoeias, fda online sites etc.
DST M.Pharm 021	Study of depth of the drug and its available formulations and problems related with that available problems.
DST M.Pharm 022	Development and assessment of novel in-situ ocular gels of ketorolac tromethamine
DST M.Pharm 023	Dissolution improvement of weakly soluble drugs using hot melt extrusion technology.
DST M.Pharm 024	Dissolution rate enhancement of glimepiride and olanzapine by spray drying technique.
DST M.Pharm 025	Enhancement of dissolution rate of aceclofenac with meglumin as a novel ternary component
DST M.Pharm 026	Formulation and estimate of aceclofenac topical emulgels.
DST M.Pharm 027	Lipid based solid self-emulsifying delivery system of pitavastatin calcium: development and characterization
DST M.Pharm 028	Design and characterization of paclitaxel loaded nanoparticles with piperine
DST M.Pharm 029	Development and characterization of topical microemulsion of tranexamic acid
DST M.Pharm 030	Exploring career advancement of pharmacy support staff within two queensland hospitals: a qualitative study
DST M.Pharm 031	Significant predictors for topiramate pharmacokinetics: a systematic review of population pharmacokinetic studies
DST M.Pharm 032	Nanocapsule formation by interfacial polymer deposition following solvent displacement
DST M.Pharm 033	Stability indicating reverse phase high performance liquid chromatography method for simultaneous estimation of allantoin, hydroquinone and tretenoin in cream formulation.
DST M.Pharm 034	Process control and end-point determination of a fluid bed granulation by application of near infra-red spectroscopy
DST M.Pharm 035	Chirality and its importance in pharmaceutical field-an overview
DST M.Pharm 036	Recent advances in nanosponges as drug delivery system
DST M.Pharm 037	Fabrication of mebendazole loaded solid lipid nanoparticles: formulation, optimization, characterization, stabilization, and in-vitro evaluation
DST M.Pharm 038	In vitro evaluation and characterization of the nanoparticulate system of novel taxane derivative
DST M.Pharm 039	A comprehensive review on solid lipid nanoparticles as delivery vehicle for enhanced pharmacokinetic and pharmacodynamic activity of poorly soluble drugs
DST M.Pharm 040	Building molecular complexity from inert c-h bonds
DST M.Pharm 041	Synthesizing novel self assembled monolayer conductive polymers for improving biocompatible and norotrophic devices
DST M.Pharm 042	Synthesis of mukanadin b and analogues as possible neuroprotective agents
DST M.Pharm 043	Aza-lignan project in medicinal chemistry
DST M.Pharm 044	Biomimetic synthesis of natural products
DST M.Pharm 045	Synthesis of biologically active lignan natural products via an acyl-claisen rearrangement and an unusual 1,4-diaryl rearrangement
DST M.Pharm 046	C-h functionalisation in the synthesis of complex alkaloids
DST M.Pharm 047	Total synthesis of cage indole alkaloids
DST M.Pharm 048	Synthetic studies towards indole-based alkaloids
DST M.Pharm 049	Synthesis of bioactive natural products and associated analogues
DST M.Pharm 050	Complex alkaloid synthesis by c-h functionalization
DST M.Pharm 051	Studies towards the asymmetric synthesis of 1,4-benzodioxane neolignans
DST M.Pharm 052	Total synthesis of the dineolignan ophiocerol and derivatives
DST M.Pharm 053	Three dimensional conformation, synthesis, characterisation of peptides and their application in devising drugs
DST M.Pharm 054	Chiral sulfoxide auxiliaries for the asymmetric synthesis of benzannulated spiroketals
DST M.Pharm 055	Design and synthesis of polypeptides as potential drug carriers for therapeutic purposes
DST M.Pharm 056	Design, synthesis and structural activity relationship of antimicrobial peptides against multi-drug resistant organisms
DST M.Pharm 057	Peptide conjugation to build tumour selectivity into potential chemotherapeutic agents
DST M.Pharm 058	Studies towards the identification and synthesis of proteins expressed in intact and degenerate bovine cartilage
DST M.Pharm 059	Studies towards the design, synthesis and analysis of bioactive peptides
DST M.Pharm 060	The synthesis of natural product containing polymers for use in the prevention of biofilms
DST M.Pharm 061	Bioactive marine natural products
DST M.Pharm 062	The synthesis and investigation of marine natural products as potential anti-fouling agents
DST M.Pharm 063	Studies towards onchidal’s acetycholine esterase inhibitory activity
DST M.Pharm 064	Total synthesis of terreinol, a spiroketal natural product, and investigation into enantioselective oxidative spiroketalisation
DST M.Pharm 065	Synthesis of marine derived natural products aigialospirol and its analogues
DST M.Pharm 066	Total synthesis of lasionectrin and related analogues as novel anti-malaria agents
DST M.Pharm 067	Asymmetric gold-catalysed synthesis of the paecilospirone spiroacetal
DST M.Pharm 068	Crystallization processes in drug innovations and treatment conveyance plan
DST M.Pharm 069	Portrayal of momentary water ingestion properties of drug excipients
DST M.Pharm 070	Redesigning hydrogen gas detecting properties of changed graphen
DST M.Pharm 071	Medication of antibiotic opposing bacteria by nanoparticles
DST M.Pharm 072	Photocatalytic oxidation utilizing nanoparticles for color evacuation
DST M.Pharm 073	Improvement and validation of stability indicating hplc method
DST M.Pharm 074	Improvement of controlled release matrix formulations of the chronobiotic hormone
DST M.Pharm 075	Liposomes for the transdermal delivery of piroxicam
DST M.Pharm 076	Business strategies of nutraceuticals in world market
DST M.Pharm 077	Key development aspects of pharmaceuticals and bioavailability
DST M.Pharm 078	Market analysis of 3rd international conference on vaccine & vaccinatio
DST M.Pharm 079	Plant science and biotechnology.
DST M.Pharm 080	The design and implementation of a computer pharmaceutical centre (a case study of osco pharmaceutical centre warri, delta state).
DST M.Pharm 081	Modern biotechnology and diginity of human life; an ethical analysis.
DST M.Pharm 082	Pharmaceutical system.
DST M.Pharm 083	Design and implementation of a computer pharmaceutical centre.
DST M.Pharm 084	Enterprise risk management in pharmaceutical company
DST M.Pharm 085	The impact of promotion on consumer patronage of pharmaceutical companies.
DST M.Pharm 086	The determinant of audit fee of listed pharmaceutical firms in nigeria.
DST M.Pharm 087	Automating inventory management in the pharmaceutical unit of the hospital.
DST M.Pharm 088	Online registration of pharmaceutical company and drug verification system.
DST M.Pharm 089	Design and implementation of a computerization pharmaceutical management information system.
DST M.Pharm 090	Working capital management and profitability of listed pharmaceutical firms in nigeria
DST M.Pharm 091	The effect of marginal cost elements on the financial performance of pharmaceutical companies in nigeria.
DST M.Pharm 092	Consumer protection and drug marketing in nigeria (a case study of juhel pharmaceutical company enugu).
DST M.Pharm 093	Impact of marketing research in a small scale company a case study of juhel pharmaceutical enugu.
DST M.Pharm 094	The design and implementation of a computerized standard appraisal system for pharmaceutical products (a case study of nafdac nigeria).
DST M.Pharm 095	The effects of audit failures on corporate organisations in nigeria (a case study of matador pharmaceutical enterprise akure).
DST M.Pharm 096	Analysis of caffeine in pharmaceutical and personal care products in fish and water samples from ureje dam, ekiti state, nigeria.
DST M.Pharm 097	A total of 34 indigenously manufactured pharmaceutical oral liquids were purchased from different potent medicine stores in owerri main market from august to october.
DST M.Pharm 098	Importance of packaging in the marketing of pharmaceutical products”. (a case study of may and baker nigeria limited)”.
DST M.Pharm 099	Bio-availability of drugs, including factors affecting it
DST M.Pharm 100	complete data base of drug available by any source like internet, libraries etc.
DST M.Pharm 101	Complete physico0chemical parameter of pure drug.
DST M.Pharm 102	Study of complete drug profile from authenticated sources like pharmacopoeias, FDA online sites etc.
DST M.Pharm 103	study of depth of the drug and its available formulations and problems related with that available problems.
DST M.Pharm 104	Development and assessment of Novel In-situ Ocular gels of Ketorolac Tromethamine
DST M.Pharm 105	Dissolution improvement of weakly soluble drugs using hot melt Extrusion Technology.
DST M.Pharm 106	Dissolution rate Enhancement of Glimepiride and olanzapine by spray drying technique.
DST M.Pharm 107	Enhancement of dissolution rate of aceclofenac with meglumin as a novel ternary component
DST M.Pharm 108	Formulation and estimate of Aceclofenac Topical Emulgels.
DST M.Pharm 109	Formulation and estimation of atomoxetine HCL buccal drug delivery system
DST M.Pharm 110	Formulation and assessment of capecitabine tablets for colon specific drug delivery system
DST M.Pharm 111	Formulation and Evaluation of cyclobenzaprine hydrochloride loaded sustained release microspheres.
DST M.Pharm 112	Formulation and evaluation of diclofenac sodium matrix tablets using new natural polymer
DST M.Pharm 113	Formulation and evaluation of duloxetine HCL delayed release enteric coated capsules
DST M.Pharm 114	Formulation and evaluation of fast disintergrating tablets and films for carbinoxamine maleate
DST M.Pharm 115	Formulation and evaluation of frusemide semi solid matrix capsules by liquid filling technology
DST M.Pharm 116	Formulation and Evaluation of Glipizide microemulsion.
DST M.Pharm 117	Formulation and evaluation of implantable drug delivery system for temozolamide
DST M.Pharm 118	Formulation and evaluation of ornidazole topical emulgels
DST M.Pharm 119	Formulation and Evaluation pantoprazole sodium enteric coated tablets using different super disintegrants.
DST M.Pharm 120	Screening, optimization and characterization of polymers for orally dissolving films.